近期论文
查看导师新发文章
（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）
[1] Li X#, Zhang X#, Zhao S#, Pei S, Sun J, Dong L, Pan X, Wang W, Liu H, Huang Y, Liu T, Deng J, Hu C, Lv C, Su J, Chen X*, Yin M*. The dynamically evolving cell states and ecosystem from benign nevi to melanoma. Clin Cancer Res. 2025 Mar 17. doi: 10.1158/1078-0432.CCR-24-2971.（Q1, 10.4）
[2] Wang W#, Li X#*, Hu R, Dong L, Pei S, Jin L, Gao Q, Chen X*, Yin M*. BET inhibitor in combination with Bacillus Calmette-Guérin vaccine enhances antitumor efficacy and orchestrates T cell reprogramming for melanoma. Cell Rep Med. 2025 Mar 18;6(3):101995. （Q1, 11.7）
[3] Dong L#, Hu S#, Li X, Pei S, Jin L, Zhang L, Chen X*, Min A*, Yin M*. SPP1+ TAM Regulates the Metastatic Colonization of CXCR4+ Metastasis-Associated Tumor Cells by Remodeling the Lymph Node Microenvironment. Adv Sci (Weinh). 2024 Nov; 11(44): e2400524. doi: 10.1002/advs.202400524.（Q1, 15.1）
[4] Pan X#, Li X#, Dong L#, Liu T, Zhang M, Zhang L, Zhang X, Huang L, Shi W, Sun H, Fang Z, Sun J, Huang Y, Shao H, Wang Y, Yin M*. Tumour vasculature at single-cell resolution. Nature. 2024 Aug; 632(8024): 429-436.（Q1, 50.5）
[5] Chen M#, Shan H#, Tao Q, Hu R, Sun Q, Zheng M, Chen Z, Lin Q, Yin M*, Zhao S*, Chen X*, Chen Z*. Mimicking Tumor Metastasis Using a Transwell-Integrated Organoids-On-a-Chip Platform. Small. 2024 Jul; 20(27): e2308525. doi: 10.1002/smll.202308525. （Q1, 13.3）
[6] Hu R#, Hou H#, Li Y#, Zhang M, Li X, Chen Y, Guo Y, Sun H, Zhao S, Liao M, Cao D, Yan Q*, Chen X*, Yin M*. Combined BET and MEK Inhibition synergistically suppresses melanoma by targeting YAP1. Theranostics. 2024 Jan 1; 14(2): 593-607. doi:10.7150/thno.85437. （Q1, 12.4）
[7] Fang Z#, Liu T#, Zheng R, A J, Yin M*, Li M*. stAA: adversarial graph autoencoder for spatial clustering task of spatially resolved transcriptomics. Brief Bioinform. 2023 Nov 22;25(1):bbad500. doi: 10.1093/bib/bbad500. (Q1, 13.994)
[8] Deng J#, Pan T#, Lv C, Cao L, Li L, Zhou X, Li G, Li H, Vicencio JM, Xu Y, Wei F, Wang Y, Liu Z*, Zhou G*, Yin M*. Exosomal transfer leads to chemoresistance through oxidative phosphorylation-mediated stemness phenotype in colorectal cancer. Theranostics. 2023 Sep 11; 13(14): 5057-5074. doi: 10.7150/thno.84937.（Q1，12.4）
[9] Liu T, Fang ZY, Li X, Zhang LN, Cao DS*, Yin MZ*. Graph deep learning enabled spatial domains identification for spatial transcriptomics. Brief Bioinform. 2023 May 19, 24(3):bbad146. doi: 10.1093/bib/bbad146. （Q1，13.994）
[10] Hu R, Li Y, Guo Y, Li X, Du S, Liao M, Hou H, Sun H, Zhao S, Su J, Chen X*, Yin M*. BRD4 inhibitor suppresses melanoma metastasis via the SPINK6/EGFR-EphA2 pathway. Pharmacol Res. 2023 Jan, 187: 106609. doi: 10.1016/j.phrs.2022.106609. （Q1，10.334）
[11] Zeng F#, Li Y#, Meng Y, Sun H, He Y, Yin M*, Chen X*, Deng G*. BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression. Exp Mol Med. 2023 Feb, 55(2): 364-376. doi: 10.1038/s12276-023-00936-y. （Q1，12.8）
[12] Zhang M, Liu ZZ, Aoshima K, Cai WL, Sun H, Xu T, Zhang Y, An Y, Chen JF, Chan LH, Aoshima A, Lang SM, Tang Z, Che X, Li Y, Rutter SJ, Bossuyt V, Chen X, Rimm DL, Yin M*, Yan Q*. CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression. Sci Transl Med. 2022 Feb 2, 14 (630): eabf5473. doi: 10.1126/scitranslmed.abf5473. （Q1,17.1）
[13] Deng G#, Zeng F#, He Y, Meng Y, Sun H, Su J, Zhao S, Cheng Y, Chen X*, Yin M*. EEF2K silencing inhibits tumour progression through repressing SPP1 and synergizes with BET inhibitors in melanoma. Clin Transl Med. 2022 Feb, 12(2): e722. doi: 10.1002/ctm2.722. （Q1,10.6）
[14] Chen X, Wang K, Jiang S, Sun H, Che X, Zhang M, He J, Wen Y, Liao M, Li X, Zhou X, Song J, Ren X, Yi W, Yang J, Chen X, Yin M*, Cheng Y*. eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma. J Immunother Cancer. 2022 Mar, 10(3): e004026. doi: 10.1136/jitc-2021-004026. （Q1, 10.9）
[15] Li X#, Zhao S#, Bian X#, Zhang L, Lu L, Pei S, Dong L, Shi W, Huang L, Zhang X, Chen M, Chen X*, Yin M*. Signatures of EMT, immunosuppression, and inflammation in primary and recurrent human cutaneous squamous cell carcinoma at single-cell resolution. Theranostics, 2022 Oct 31, 12(17): 7532-7549. doi: 10.7150/thno.77528.（Q1，12.4）
[16] Yin M*, Guo Y, Hu R, Cai WL, Li Y, Pei S, Sun H, Peng C, Li J, Ye R, Yang Q, Wang N, Tao Y, Chen X*, Yan Q*. Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction. Nat Commun. 2020 Apr 14, 11(1): 1833. doi: 10.1038/s41467-020-15290-0. （Q1，14.919）
[17] Deng G, Zeng F*, Zhang L*, Chen H*, Chen X*, Yin M*. Characteristics of Pregnant COVID-19 Patients with Liver Injury. J Hepatol. 2020 Oct, 73(4): 989-991. doi: 10.1016/j.jhep.2020.06.022. （Q1，25.083）
[18] Li Z#, Yin M#, Zhang H, Ni W, Pierce RW, Zhou HJ, Min W. BMX Represses Thrombin-PAR1-Mediated Endothelial Permeability and Vascular Leakage During Early Sepsis. Circ Res. 2020 Feb 14, 126(4): 471-485. doi: 10.1161/CIRCRESAHA.119.315769. （Q1，17.367）
[19] Deng G#, Zeng F#, Su J, Zhao S, Hu R, Zhu W, Hu S, Chen X*, Yin M*. BET inhibitor suppresses melanoma progression via the noncanonical NF-κB/SPP1 pathway. Theranostics. 2020 Sep 15, 10(25): 11428-11443. doi: 10.7150/thno.47432. （Q1，11.556）
[20] Yin M#, Li X#, Tan S#, Zhou HJ, Ji W, Bellone S, Xu X, Zhang H, Santin AD, Lou G*, Min W*. Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer. J Clin Invest. 2016 Nov 1, 126(11): 4157-4173. doi: 10.1172/JCI87252. （Q1，12.784）
京公网安备 11010802027423号